Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial

Nabil Ahmed, Vita Brawley, Meenakshi Hegde, Kevin Bielamowicz, Amanda Wakefield, Alexia Ghazi, Aidin Ashoori, Oumar Diouf, Claudia Gerken, Daniel Landi, Mamta Kalra, Zhongzhen Yi, Cliona Rooney, Gianpietro Dotti, Adrian Gee, Helen Heslop, Stephen Gottschalk, Suzanne Zein-Eldin Powell, Robert G. Grossman, Winfried WelsYzonne Kew, David S. Baskin, Jonathan Zhang, Pamela New, John Hicks

Research output: Contribution to journalArticle

31 Scopus citations
Original languageEnglish (US)
Article numberO11
JournalJournal for immunotherapy of cancer
Volume3
DOIs
StatePublished - 2015

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this